Sully.ai and the 'AI employees' model: how agent teams differ from an AI scribe

Almost every tool in our catalog is an ambient scribe — a single, focused job. It listens to the consultation, drafts a structured note, and you review and sign it. Nabla, Commure, Heidi, Stenoly, Abridge: different strengths, same shape.

Sully.ai is built on a different premise. Rather than one scribe, it ships a team of role-based AI agents — reception, scribing, coding, triage, pharmacy, consulting — on one platform the company calls an "Autonomous Operating System for Healthcare." It's a genuinely different product category, and worth understanding on its own terms whether or not you end up choosing it.

This is our explainer on what Sully.ai actually is, how the agent model differs from a single-purpose scribe, and where it does and doesn't make sense.

What Sully.ai is

Sully.ai is a US-based, Y Combinator-backed healthcare-AI company. It has raised north of $30M — including a roughly $22M Series A in January 2025 (AUM Ventures, Leonis Capital, SemperVirens VC, Sequoia Scout Fund). It is young and growing fast.

The product isn't a scribe with extras bolted on. It's a suite of specialised agents, each modelled on a healthcare staff role, that plug into your existing EHR and communication tools:

• AI Scribe — ambient documentation: captures the patient–clinician conversation and drafts a structured note.
• AI Receptionist — answers patient inquiries, schedules appointments, backfills cancellations.
• AI Medical Coder — reviews the encounter and assigns ICD-10 / CPT codes.
• AI Nurse Triage — handles intake and triage of incoming patient messages.
• AI Nurse — patient assessment, medication and education support.
• AI Pharmacist — prescription verification and medication-management support.
• AI Consultant / Interpreter — back-office coordination and multilingual support.

The unifying idea: instead of wiring an ambient scribe to half a dozen separate point tools — one for scheduling, one for coding, one for patient messaging — you run them as one coordinated agent team. Sully's pitch is that the whole front-desk-to-prescription patient journey is automatable, with humans confirming each step.

How the agent model differs from a single-purpose scribe

The distinction matters because it changes what you're buying.

A scribe solves one problem extremely well. The entire product — note quality, EHR write-back, templating, latency — is optimised around turning a conversation into a clean clinical note. That focus is why the precision-focused scribes in our catalog score where they do: they do one thing, and they do it to a high standard.

An agent suite solves a workflow, not a task. Sully's bet is that the documentation note is only one of a dozen jobs around a visit — intake, eligibility checks, scheduling, coding, patient follow-up — and that owning the whole sequence beats stitching together specialists. If you're a clinic feeling the load across the front desk and back office, not just the exam room, that's a real proposition.

The trade-off is equally real. If all you want is the best possible note, an agent suite is overkill — you're buying (and onboarding, and governing) six roles to use one. The single-purpose scribes will usually give you a tighter, more focused documentation experience. Breadth and depth pull against each other, and Sully has chosen breadth.

A second structural point: the agent model is a procurement decision, not an app download. A solo clinician can self-serve onto a scribe in an afternoon. Deploying a team of agents that touch scheduling, messaging and coding is a clinic-level rollout — it changes workflows for non-clinical staff too. Sully's onboarding is demo-led for exactly this reason.

The human-in-the-loop question

With any AI that drafts clinical or billing output, the safety question is: what does the human still own?

Sully's stated model is that everything the platform produces is a draft until a person reviews and approves it — the note, the codes, the triage decision, the patient message. That's the correct posture, and it's the same one we'd expect of any tool in this category. It's also worth stress-testing in a pilot: an agent suite produces more draft outputs across more workflows than a scribe does, so the review burden is distributed across more staff roles. Make sure each role's review step is real and not rubber-stamped — the AI hallucinations guide covers how to test that deliberately.

A note on the headline numbers

Sully's marketing cites figures like a 21× ROI, a 5–15% revenue lift from better coding, and clinicians seeing more patients per month. We don't repeat vendor performance claims as fact — they're typically vendor-measured, under vendor-chosen conditions, and rarely independently audited. Treat them as directional marketing, not evidence. The thing to actually verify in a pilot is whether the coding agent improves your clean-claims rate and whether the scribe agent produces notes you'd sign without heavy editing. Those you can measure yourself.

Compliance — genuinely a strength

Where Sully is unambiguously strong is its enumerated compliance posture. It lists HIPAA + SOC 2 Type II + ISO 27001 + GDPR + PIPEDA + PDL — the broadest set of named certifications of any tool in our catalog. For an agent suite touching scheduling, messaging, coding and clinical notes — i.e. a wide PHI surface — that breadth is appropriate and reassuring.

The gap to confirm: Sully does not publicly enumerate its data-residency region or hosting specifics. For a multi-agent platform that's a fair question to put in writing before a deployment — see our HIPAA / SOC 2 / GDPR checklist.

Pricing

Sully publishes per-provider pricing, which is more transparent than most enterprise-targeted healthcare AI:

• Pro — $79/provider/month: Scribe + Chat + custom templates + 24/7 support.
• Premium — $99/provider/month: adds the EHR-integration agent, decision support, and the research / writer / interpreter agents.
• Enterprise — custom.

There's no published free tier, and onboarding is demo-led — consistent with the clinic-level nature of the product. At $79–99/provider/month it sits at the higher end for a solo clinician who only wants a scribe; it reads more sensibly priced when you're actually using several agents.

Where Sully.ai fits

Sully makes sense if:

• You're a clinic or group feeling the administrative load across the front desk and back office, not just documentation.
• You'd rather run one coordinated agent platform than integrate a scribe with separate scheduling, coding and messaging tools.
• Bundled AI coding and the broad compliance stack matter to you.
• You can run a clinic-level rollout — this is procurement, not a self-serve app.

A focused scribe makes more sense if:

• You only want the best possible clinical note. Look at our Editor's Pick Nabla, or Commure Scribe for the strongest US-market note quality we've tested.
• You're a solo clinician who needs to be running this week without a deployment project.
• You don't want to govern AI output across six staff roles.

Bottom line

Sully.ai is one of the more interesting bets in the category precisely because it isn't another ambient scribe. The "team of AI employees" model is a coherent answer to a real problem — the visit note is only one of many automatable jobs around a patient encounter — and the compliance posture backing it is the broadest we've catalogued.

The honest caveat is the one any breadth-over-depth product carries: if your need is simply the cleanest note, a focused scribe will likely serve you better, and the agent suite's surface area is overkill. Sully is best understood not as a scribe competitor but as a different category — clinic-operations automation — that happens to include scribing as one agent among several.

We score Sully.ai 8.1 / 10 — a strong, distinctive product, with the multi-agent breadth as both its biggest differentiator and its main trade-off. See the full verified data on the Sully.ai review page, or compare it against the focused scribes on the full ranking.

---

Sources: Sully.ai official site, Sully.ai products, Y Combinator company profile, Crunchbase. Funding and product details verified May 2026; confirm current specifics with the vendor.